News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Local

Kirk: No Win in Trade with Cuba

mark-kirk

It's still communist and small, he says

in Local

New Weapon against Prescription Drug Abuse

pills

Illinois may consider locks on pill bottles

in Local

Rauner Will Welcome Supreme Court Feedback on Pensions

pension

Gov-elect has always opposed the plan which passed in 2013

in Local

Many Start College, Not Enough Finish

college

IBHE promotes "Pathways to College Success"

in Local

SOS for Locks and Dams

local_news_generic

Network means $6.4B annually